Skip to main content
54019 Suchergebnisse für:

Rett-Syndrom 

sortieren nach |
"Aktualität" sortiert die Ergebnisse nach Publikationsdatum. "Relevanz" berücksichtigt auch noch andere Faktoren wie zum Beispiel die Häufigkeit der Suchbegriffe im Text.
  1. Open Access 21.05.2024 | Online First

    A meta-analysis of the efficacy and safety of trofinetide in patients with rett syndrome

    Rett syndrome (RTT) is an x-linked neurodevelopmental disease that primarily affects females, with an incidence between 1:10,000 and 1:15000 [ 1 ]. RTT develops due to a gene mutation on the long arm (q) of the X chromosome. Methyl CpG-binding …

  2. Open Access 01.12.2024 | OriginalPaper

    Safety and efficacy of trofinetide in Rett syndrome: a systematic review and meta-analysis of randomized controlled trials

    Rett syndrome is a genetic neurodevelopmental disorder that predominantly affects females, with a prevalence ranging from 1:10,000 to 1:23,000 female live births [ 1 ]. A recent systematic review and meta-analysis by Petriti et al. (2023) reported …

  3. Open Access 01.12.2024 | OriginalPaper

    Rett syndrome in Ireland: a demographic study

    Rett syndrome, originally described in the 1960’s by Andreas Rett, is an X-linked rare neurodevelopmental condition with specific clinical features [ 1 ]. It affects brain function and development, with global prevalence ranging from 5–10 cases …

  4. Open Access 16.02.2024 | OriginalPaper

    Exposure–Response Efficacy Modeling to Support Trofinetide Dosing in Individuals with Rett Syndrome

    Trofinetide is the first US Food and Drug Administration-approved treatment for Rett syndrome (RTT), a rare, genetic neurodevelopmental disorder. In almost all cases, RTT is caused by loss-of-function mutations in the gene encoding …

  5. Open Access 20.02.2024 | BriefCommunication

    Managing Gastrointestinal Symptoms Resulting from Treatment with Trofinetide for Rett Syndrome: Caregiver and Nurse Perspectives

    Rett syndrome (RTT) is a rare genetic neurodevelopmental disorder mainly affecting female individuals. Trofinetide was recently approved as the first treatment for RTT, largely on the basis of results from the phase 3 LAVENDER trial, in which …

  6. Open Access 01.12.2024 | ReviewPaper

    Treatment guidelines for rare, early-onset conditions associated with epileptic seizures: a literature review on Rett syndrome and tuberous sclerosis complex

    Rett syndrome (RTT) and tuberous sclerosis complex (TSC) are rare, single-gene disorders that can present with autism, epilepsy and intellectual disability [ 1 – 3 ]. RTT is a progressive, developmental impairment disorder that almost exclusively …

  7. Open Access 01.12.2024 | OriginalPaper

    Therapeutic effects of extracorporeal shock wave therapy on patients with spastic cerebral palsy and Rett syndrome: clinical and ultrasonographic findings

    Cerebral palsy (CP) is a motor impairment caused by damage to the developing brain. Preterm and very low birth weight babies have the greatest risk of developing CP. Other common causes of CP include intrauterine growth restriction and infection …

  8. Open Access 01.12.2024 | OriginalPaper

    An ambulatory dental treatment of a child with Rett syndrome and limited mouth opening under muscle relaxant-free general anesthesia: a case report

    Rett Syndrome (RTT) is a severe, rare, and progressive developmental disorder with intellectual disability [ 1 ]. Mutations of the methyl-CpG binding protein 2 (MECP2) gene on the X chromosome are the most prevalent cause of classical RTT cases [ 2 …]. Characteristic symptoms of RTT include partial or complete loss of acquired spoken language and motor skills, repetitive hand movements, breathing irregularities and seizures. RTT patients may also suffer from scoliosis, wasting, dystonia and bradykinesia. Many patients are wheelchair and/or gastrostomy-tube dependent in their motor deterioration stage [

  9. Open Access 01.12.2023 | OriginalPaper

    Mitochondrial modulation with leriglitazone as a potential treatment for Rett syndrome

    Rett syndrome (OMIM # 312750) is a neurodevelopmental disorder that affects 1 in 10,000 people, mostly girls. Usually caused by de novo mutations in the X-linked MECP2 gene, it is a clinically and molecularly complex disorder [ 1 ]. It is …

  10. Open Access 01.12.2023 | OriginalPaper

    Effect of presentation rate on auditory processing in Rett syndrome: event-related potential study

    Rett syndrome (RS) is a neurodevelopmental disorder associated with mutations in the X-linked gene MECP2 [ 1 ]. This disease is characterized by a variety of physiological, motor, and cognitive deficits that usually follow relatively typical …

  11. Open Access 01.12.2023 | OriginalPaper

    Top caregiver concerns in Rett syndrome and related disorders: data from the US natural history study

    Rett syndrome (RTT) is a severe neurodevelopmental disorder (NDD) that predominantly, but not exclusively [ 1 ], affects girls and women and is characterized by regression with loss of acquired spoken language and volitional hand use, disrupted or …

  12. Open Access 01.12.2023 | OriginalPaper

    Epidemiology and patient journey of Rett syndrome in the United States: a real-world evidence study

    Rett syndrome (RTT) is a severe neurodevelopmental disorder that almost exclusively affects females, with an estimated incidence of 1 in 10,000 females by the age of 12 in the United States (US) [ 1 , 2 ]. RTT is characterized by normal development …

  13. Open Access 01.12.2023 | OriginalPaper

    MECP2 germline mosaicism plays an important part in the inheritance of Rett syndrome: a study of MECP2 germline mosaicism in males

    In current common practice, a mutation in a proband is considered as “de novo” if the mutant alleles were detected in the peripheral blood DNA of the proband but neither in that of the parents. Theoretically, de novo mutations (DNMs) are mutations …

  14. Open Access 01.12.2023 | ReviewPaper

    Global prevalence of Rett syndrome: systematic review and meta-analysis

    Rett syndrome (RTT) is a rare, severe neurodevelopmental disorder that affects almost exclusively females. The syndrome was first described in 1966 by Andreas Rett in the German medical literature [ 1 ]. However, RTT was not internationally …

  15. 01.02.2023 | Letter

    Extension of the Lifespan of a Mouse Model of Rett Syndrome by Intracerebroventricular Delivery of MECP2

  16. Open Access 01.07.2022 | OriginalPaper

    Clinical and Preclinical Evidence for M1 Muscarinic Acetylcholine Receptor Potentiation as a Therapeutic Approach for Rett Syndrome

    Rett syndrome (RTT) is a neurodevelopmental disorder that is characterized by developmental regression, loss of communicative ability, stereotyped hand wringing, cognitive impairment, and central apneas, among many other symptoms. RTT is caused by …

  17. 2020 | OriginalPaper | Buchkapitel

    Rett-Syndrom

    Das Rett-Syndrom wurde 1966 erstmalig vom Wiener Kinderneurologen Andreas Rett beschrieben. Er fand eine Entwicklungsstörung bei Mädchen mit wieder zu erkennenden Handstereotypien. Zusätzlich beschrieb er eine Hyperammonämie bei diesen Kindern.

    verfasst von:
    Bernd Wilken, Folker Hanefeld
    Erschienen in:
    Pädiatrie (2020)
  18. Open Access 01.12.2022 | OriginalPaper

    Hypoventilation and sleep hypercapnia in a case of congenital variant-like Rett syndrome

    Rett syndrome (RS) (OMIM #312750) is a severe X-linked dominant neurodevelopmental disorder, affecting one baby every 10.000 live-born, almost exclusively female. The congenital variant of Rett syndrome (CRS) accounts for just 5–7% of all cases …

  19. Open Access 28.04.2022 | OriginalPaper

    Clinical and genetic correlations of scoliosis in Rett syndrome

    Rett syndrome (RTT) is a neurodevelopmental disorder predominantly linked to MECP2 gene mutations, affecting one female birth in 10,000/15,000 [ 1 ]. Scoliosis is an associated condition of RTT, with a high clinical impact [ 2 ]. Complications …

  20. 10.05.2022 | AAN-Jahrestagung 2022 | Kongressbericht | Online-Artikel
    Phase-3-Studie

    Erfolg mit Tripeptid gegen Rett-Syndrom

    Hoffnung für Menschen mit Rett-Syndrom. Mit dem neuen Wirkstoff Trofinetid konnten Behandelnde in einer Phase-3-Studie sowohl die Symptomatik lindern als auch den klinischen Gesamteindruck der Betroffenen verbessern. Allerdings sind die Effektstärken eher gering.

Suchergebnisse filtern:

Suchoperatoren:

„ ... ... “ Findet Dokumente mit genau dieser Wortgruppe in exakt dieser Schreibweise und Reihenfolge (z.B., "rheumatische Beschwerden").
AND / UND Findet Dokumente, in denen beide Begriffe zusammen vorkommen (z.B., alkohol UND demenz).
OR / ODER Findet Dokumente, in denen einer der beiden oder beide Begriffe vorkommen (z.B., hiv ODER aids).
Leerzeichen Findet Dokumente, in denen alle Begriffe vorkommen. Der Leerschritt wird als UND interpretiert (z.B., isolierte systolische hypertonie).
NOT / NICHT Findet Dokumente, in denen der Begriff nach NOT nicht vorkommt (z.B., sars NOT sars-cov-2).
COUNT(...)>n Findet Dokumente, in denen der gesuchte Begriff mehr als n mal vorkommt. n steht für eine beliebige Anzahl (z.B., COUNT(mammakarzinom)>8).
NEAR(..., ..., ) Findet Dokumente, in denen beide Begriffe in beliebiger Reihenfolge innerhalb von maximal n Worten zueinander stehen. Empfehlung: wählen Sie zwischen 15 und 30 als maximale Wortanzahl (z.B., NEAR(covid, diabetes,20)).
* Findet Dokumente, in denen der Begriff in Wortvarianten vorkommt, wobei diese VOR, HINTER oder VOR und HINTER dem Suchbegriff anschließen können (z.B., thrombose*, *thrombose, *thrombose*).
? Findet Dokumente mit dem Suchbegriff in verschiedenen Schreibweisen, hier mit s oder z, also organisation und organization. Das ? steht für eine einzige Stelle (z.B., organi?ation).
& + - Sonderzeichen werden als UND interpretiert (z.B., Diagnose + Therapie).

Sie können Operatoren mit Ihrer Suchanfrage kombinieren, um diese noch präziser einzugrenzen.

Fahren Sie mit der Maus über den Suchoperator, um eine Erklärung seiner Funktionsweise anzuzeigen.